首页 > 最新文献

Revista medica de Chile最新文献

英文 中文
[Epidemics in the Department of Ovalle in the Late 19th and Early 20th Centuries: Reports from the Revista Médica de Chile and Other Sources]. [19世纪末和20世纪初奥瓦莱省的流行病:来自智利档案和其他来源的报告]。
IF 0.3 Pub Date : 2025-09-01 Epub Date: 2025-09-02 DOI: 10.4067/s0034-98872025000900672
Manuel E Cortés
{"title":"[Epidemics in the Department of Ovalle in the Late 19th and Early 20th Centuries: Reports from the Revista Médica de Chile and Other Sources].","authors":"Manuel E Cortés","doi":"10.4067/s0034-98872025000900672","DOIUrl":"https://doi.org/10.4067/s0034-98872025000900672","url":null,"abstract":"","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 9","pages":"672-673"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145194327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The Radiologist's Role in Multidisciplinary Teams: Bioethical Implications of Their Participation]. [放射科医生在多学科团队中的角色:他们参与的生物伦理含义]。
IF 0.3 Pub Date : 2025-09-01 Epub Date: 2025-09-02 DOI: 10.4067/s0034-98872025000900670
Cristian Gübelin Saravia, Raúl Collado Hung
{"title":"[The Radiologist's Role in Multidisciplinary Teams: Bioethical Implications of Their Participation].","authors":"Cristian Gübelin Saravia, Raúl Collado Hung","doi":"10.4067/s0034-98872025000900670","DOIUrl":"https://doi.org/10.4067/s0034-98872025000900670","url":null,"abstract":"","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 9","pages":"670-671"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145194325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Dupilumab for the Management of Moderate-to-Severe Atopic Dermatitis in Pediatric Patients in Chile: A Series of 10 Clinical Cases]. 【Dupilumab治疗智利儿童中重度特应性皮炎:一系列10例临床病例】。
IF 0.3 Pub Date : 2025-09-01 Epub Date: 2025-09-02 DOI: 10.4067/s0034-98872025000900610
Ignacia Fuentes Escobar, Marie-Chantal Caussade, Cristóbal Lecaros Cornejo, María Trinidad Hasbún Zegpi

Atopic dermatitis (AD) is a common chronic inflammatory disease with a variable course, particularly prevalent in the pediatric population. Targeted therapies-such as monoclonal antibodies (mAbs) and Janus kinase (JAK) inhibitors-represent emerging treatment options. Dupilumab was the first mAb approved by the U.S. Food and Drug Administration (FDA) for the treatment of severe AD.

Aim: To describe a case series of patients under 12 years of age with moderate-to-severe AD treated with dupilumab, and to provide practical considerations for its clinical use.

Methods: A multicenter, retrospective, descriptive observational study was conducted, including pediatric patients with moderate-to-severe AD treated with dupilumab. Demographic, clinical, and treatment response variables were collected.

Results: Ten patients with moderate-to-severe AD (mean baseline EASI score of 24.4 [SD 12]) and a history of prior treatment failure were included. A mean reduction of 13.5 points in EASI score [range: 5.9-25.8] was observed after 6 months of treatment, along with a sustained decrease in individual scores over time. Follow-up duration ranged from 12 to 24 months. Reported adverse effects were mild and did not lead to treatment discontinuation.

Conclusions: The findings of this study are consistent with existing literature supporting the efficacy and safety of dupilumab in children under 12 years of age with moderate-to-severe AD. Furthermore, the study provides practical guidance for its use in real-world clinical settings.

特应性皮炎(AD)是一种常见的慢性炎症性疾病,病程多变,在儿科人群中尤为普遍。靶向治疗,如单克隆抗体(mab)和Janus激酶(JAK)抑制剂,代表了新兴的治疗选择。Dupilumab是美国食品和药物管理局(FDA)批准用于治疗严重阿尔茨海默病的首个单抗。目的:描述一组12岁以下中重度AD患者接受dupilumab治疗的病例系列,为其临床应用提供实际考虑。方法:开展了一项多中心、回顾性、描述性观察性研究,包括接受dupilumab治疗的中重度AD患儿。收集人口统计学、临床和治疗反应变量。结果:纳入10例中重度AD患者(平均基线EASI评分为24.4 [SD 12]),既往有治疗失败史。治疗6个月后,观察到EASI评分平均下降13.5分[范围:5.9-25.8],随着时间的推移,个体评分持续下降。随访时间为12 ~ 24个月。报告的不良反应是轻微的,没有导致治疗中断。结论:本研究结果与现有文献一致,支持dupilumab治疗12岁以下中重度AD患儿的有效性和安全性。此外,该研究为其在实际临床环境中的应用提供了实用指导。
{"title":"[Dupilumab for the Management of Moderate-to-Severe Atopic Dermatitis in Pediatric Patients in Chile: A Series of 10 Clinical Cases].","authors":"Ignacia Fuentes Escobar, Marie-Chantal Caussade, Cristóbal Lecaros Cornejo, María Trinidad Hasbún Zegpi","doi":"10.4067/s0034-98872025000900610","DOIUrl":"10.4067/s0034-98872025000900610","url":null,"abstract":"<p><p>Atopic dermatitis (AD) is a common chronic inflammatory disease with a variable course, particularly prevalent in the pediatric population. Targeted therapies-such as monoclonal antibodies (mAbs) and Janus kinase (JAK) inhibitors-represent emerging treatment options. Dupilumab was the first mAb approved by the U.S. Food and Drug Administration (FDA) for the treatment of severe AD.</p><p><strong>Aim: </strong>To describe a case series of patients under 12 years of age with moderate-to-severe AD treated with dupilumab, and to provide practical considerations for its clinical use.</p><p><strong>Methods: </strong>A multicenter, retrospective, descriptive observational study was conducted, including pediatric patients with moderate-to-severe AD treated with dupilumab. Demographic, clinical, and treatment response variables were collected.</p><p><strong>Results: </strong>Ten patients with moderate-to-severe AD (mean baseline EASI score of 24.4 [SD 12]) and a history of prior treatment failure were included. A mean reduction of 13.5 points in EASI score [range: 5.9-25.8] was observed after 6 months of treatment, along with a sustained decrease in individual scores over time. Follow-up duration ranged from 12 to 24 months. Reported adverse effects were mild and did not lead to treatment discontinuation.</p><p><strong>Conclusions: </strong>The findings of this study are consistent with existing literature supporting the efficacy and safety of dupilumab in children under 12 years of age with moderate-to-severe AD. Furthermore, the study provides practical guidance for its use in real-world clinical settings.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 9","pages":"610-618"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145194361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Guidelines for the Transmission of Sensitive Medical Information via Secure Channels]. [通过安全渠道传输敏感医疗信息的准则]。
IF 0.3 Pub Date : 2025-09-01 Epub Date: 2025-09-02 DOI: 10.4067/s0034-98872025000900667
Fabián Villena
{"title":"[Guidelines for the Transmission of Sensitive Medical Information via Secure Channels].","authors":"Fabián Villena","doi":"10.4067/s0034-98872025000900667","DOIUrl":"https://doi.org/10.4067/s0034-98872025000900667","url":null,"abstract":"","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 9","pages":"667-669"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145194350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Appreciative Review of the First Report of Familial Hypocalciuric Hypercalcemia in Chile: A Case of PTH-Dependent Hypercalcemia After Parathyroidectomy]. [对智利家族性低钙血症高钙血症第一份报告的赞赏回顾:甲状旁腺切除术后甲状旁腺素依赖性高钙血症1例]。
IF 0.3 Pub Date : 2025-08-01 DOI: 10.4067/s0034-98872025000800604
Ilker Sengul, Demet Sengul
{"title":"[Appreciative Review of the First Report of Familial Hypocalciuric Hypercalcemia in Chile: A Case of PTH-Dependent Hypercalcemia After Parathyroidectomy].","authors":"Ilker Sengul, Demet Sengul","doi":"10.4067/s0034-98872025000800604","DOIUrl":"https://doi.org/10.4067/s0034-98872025000800604","url":null,"abstract":"","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 8","pages":"604-605"},"PeriodicalIF":0.3,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Complications of Laparoscopic Versus Minimally Invasive Peritoneal Dialysis Catheter Installation]. [腹腔镜与微创腹膜透析置管的并发症]。
IF 0.3 Pub Date : 2025-08-01 DOI: 10.4067/s0034-98872025000800544
Verónica Lanas-Madrid, Ignacio Gacitúa, Rubén Torres R, Luis Toro, Antonella Sanguineti, Cintia Gaete, José Matías Robles, Karin Bravo, Catalina Pumarino, Manuel Figueroa-Giralt

Currently, the techniques for installing peritoneal dialysis catheters are divided into advanced laparoscopic (LAP) or minimally invasive (MMI) methods, which include percutaneous and mini-laparotomy approaches. International registries don't favor one technique or operator (surgeon or nephrologist) over the other.

Aim: To compare early and late complications of CPD installation via MMI by a nephrologist versus LAP.

Methods: This is a retrospective study of the patient database from the Hospital Clínico de la Universidad de Chile between January 2014 and August 2022, who underwent CPD installation. Early and late complications were evaluated, with a 30-day limit from the procedure. STATA 14 software was used, employing a p<0.05 for statistical significance.

Results: A total of 264 patients were identified, with a mean age of 53.4 years. 50% were women, and 26.9% were diabetic. In 61.7% of CPDs, the MMI approach was used. The overall complication rate was 43.9%, with early complications accounting for 27.6% of these. The most frequent early complication was repositioning (7.6%), with 80% occurring in the MMI group. For late complications, peritonitis was the most frequent (44%). There was no mortality associated with the procedure. Comparing MMI and LAP groups, no statistically significant differences were found in early or late complications (p= 0.21 and p= 0.11, respectively). Analysis of the repositioning subgroup also showed no superiority of either technique (MMI: 9.8% vs LAP 4%; p= 0.096).

Conclusions: The LAP approach is not superior to MMI performed by a nephrologist in terms of early or late complications or overall mortality. However, a trend towards a lower repositioning rate was observed in the LAP group.

目前,安装腹膜透析导管的技术分为高级腹腔镜(LAP)或微创(MMI)方法,包括经皮和小剖腹手术方法。国际注册机构不会偏向某一种技术或操作人员(外科医生或肾病专家)。目的:比较肾科医师通过MMI和LAP安装CPD的早期和晚期并发症。方法:对2014年1月至2022年8月期间在智利大学Clínico医院接受CPD安装的患者数据库进行回顾性研究。评估早期和晚期并发症,手术后30天限制。结果:共确定264例患者,平均年龄53.4岁。其中50%为女性,26.9%为糖尿病患者。61.7%的CPDs采用了MMI方法。总并发症发生率为43.9%,其中早期并发症占27.6%。最常见的早期并发症是复位(7.6%),其中80%发生在MMI组。晚期并发症以腹膜炎最为常见(44%)。没有与手术相关的死亡率。MMI组与LAP组比较,早、晚期并发症发生率差异无统计学意义(p= 0.21、p= 0.11)。重新定位亚组分析也显示两种技术均无优势(MMI: 9.8% vs LAP: 4%; p= 0.096)。结论:在早期或晚期并发症或总死亡率方面,LAP方法并不优于肾科医生进行的MMI。然而,在LAP组中观察到低重新定位率的趋势。
{"title":"[Complications of Laparoscopic Versus Minimally Invasive Peritoneal Dialysis Catheter Installation].","authors":"Verónica Lanas-Madrid, Ignacio Gacitúa, Rubén Torres R, Luis Toro, Antonella Sanguineti, Cintia Gaete, José Matías Robles, Karin Bravo, Catalina Pumarino, Manuel Figueroa-Giralt","doi":"10.4067/s0034-98872025000800544","DOIUrl":"https://doi.org/10.4067/s0034-98872025000800544","url":null,"abstract":"<p><p>Currently, the techniques for installing peritoneal dialysis catheters are divided into advanced laparoscopic (LAP) or minimally invasive (MMI) methods, which include percutaneous and mini-laparotomy approaches. International registries don't favor one technique or operator (surgeon or nephrologist) over the other.</p><p><strong>Aim: </strong>To compare early and late complications of CPD installation via MMI by a nephrologist versus LAP.</p><p><strong>Methods: </strong>This is a retrospective study of the patient database from the Hospital Clínico de la Universidad de Chile between January 2014 and August 2022, who underwent CPD installation. Early and late complications were evaluated, with a 30-day limit from the procedure. STATA 14 software was used, employing a p<0.05 for statistical significance.</p><p><strong>Results: </strong>A total of 264 patients were identified, with a mean age of 53.4 years. 50% were women, and 26.9% were diabetic. In 61.7% of CPDs, the MMI approach was used. The overall complication rate was 43.9%, with early complications accounting for 27.6% of these. The most frequent early complication was repositioning (7.6%), with 80% occurring in the MMI group. For late complications, peritonitis was the most frequent (44%). There was no mortality associated with the procedure. Comparing MMI and LAP groups, no statistically significant differences were found in early or late complications (p= 0.21 and p= 0.11, respectively). Analysis of the repositioning subgroup also showed no superiority of either technique (MMI: 9.8% vs LAP 4%; p= 0.096).</p><p><strong>Conclusions: </strong>The LAP approach is not superior to MMI performed by a nephrologist in terms of early or late complications or overall mortality. However, a trend towards a lower repositioning rate was observed in the LAP group.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 8","pages":"544-551"},"PeriodicalIF":0.3,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Challenges of Updating the Family Health Plan in Chile (2024)]. [更新智利家庭健康计划的挑战(2024年)]。
IF 0.3 Pub Date : 2025-08-01 DOI: 10.4067/s0034-98872025000800576
Dino Sepúlveda, María José Guzmán, Vania Zarzar, Maite González, Juan Pablo Rubio, Rafael Araos, Johanna Acevedo

The Family Health Plan (FHP) outlines healthcare interventions to be implemented at the primary healthcare level (PHC) and serves as a basis plan for calculating transfers to this level of care. Its updates align with the current technical and programmatic guidelines from the Ministry of Health (MINSAL), although they are not necessarily explicitly linked to the regulatory coverage instruments established by MINSAL, showing significant differences between these and its own definitions. As such, the FHP presents particular challenges for its coordinated updating alongside other coverage systems.

Aim: To develop a structural and normative classification of the healthcare interventions included in the FHP.

Methods: From a disaggregated list of interventions included in the latest FHP decree, we classified those corresponding to each coverage system. We also identified those interventions to be carried out in PHC that are not included in the FHP. Finally, we classified the services according to whether they constituted a public health good, a service within the general guarantee system, a service within a system of explicit guarantees (GES), or a minimum PHC service.

Results: A total of 220 interventions to be carried out in PHC were identified, of which only 176 were recorded in the FHP. The majority of interventions in the FHP (80) did not have an explicit relationship with any coverage system. Of the 44 interventions that should be provided in PHC but are not included in the FHP, eleven corresponded to GES interventions.

Conclusions: The interventions included in the FHP originate from diverse regulatory frameworks, which facilitates discrepancies between some of these coverage regimes and the FHP.

《家庭保健计划》概述了将在初级保健一级实施的保健干预措施,并作为计算向初级保健一级转移的基本计划。它的更新与卫生部目前的技术和规划准则保持一致,尽管它们不一定与卫生部制定的监管范围文书明确联系起来,表明这些文书与其自己的定义之间存在重大差异。因此,FHP对其与其他覆盖系统的协调更新提出了特别的挑战。目的:对FHP中包含的医疗保健干预措施进行结构和规范分类。方法:从最新FHP法令中包含的干预措施分类列表中,我们对每个覆盖系统对应的干预措施进行了分类。我们还确定了在初级保健国家开展的、不包括在FHP中的干预措施。最后,我们根据服务是否构成公共卫生产品、一般保障体系内的服务、明确保障体系(GES)内的服务或最低初级保健服务对这些服务进行了分类。结果:在初级保健中确定了总共220项干预措施,其中只有176项在FHP中记录。FHP中的大多数干预措施(80项)与任何覆盖系统都没有明确的关系。在初级保健应提供但未包括在FHP中的44项干预措施中,有11项与GES干预措施相对应。结论:FHP中包括的干预措施来自不同的监管框架,这导致了其中一些覆盖制度与FHP之间的差异。
{"title":"[Challenges of Updating the Family Health Plan in Chile (2024)].","authors":"Dino Sepúlveda, María José Guzmán, Vania Zarzar, Maite González, Juan Pablo Rubio, Rafael Araos, Johanna Acevedo","doi":"10.4067/s0034-98872025000800576","DOIUrl":"https://doi.org/10.4067/s0034-98872025000800576","url":null,"abstract":"<p><p>The Family Health Plan (FHP) outlines healthcare interventions to be implemented at the primary healthcare level (PHC) and serves as a basis plan for calculating transfers to this level of care. Its updates align with the current technical and programmatic guidelines from the Ministry of Health (MINSAL), although they are not necessarily explicitly linked to the regulatory coverage instruments established by MINSAL, showing significant differences between these and its own definitions. As such, the FHP presents particular challenges for its coordinated updating alongside other coverage systems.</p><p><strong>Aim: </strong>To develop a structural and normative classification of the healthcare interventions included in the FHP.</p><p><strong>Methods: </strong>From a disaggregated list of interventions included in the latest FHP decree, we classified those corresponding to each coverage system. We also identified those interventions to be carried out in PHC that are not included in the FHP. Finally, we classified the services according to whether they constituted a public health good, a service within the general guarantee system, a service within a system of explicit guarantees (GES), or a minimum PHC service.</p><p><strong>Results: </strong>A total of 220 interventions to be carried out in PHC were identified, of which only 176 were recorded in the FHP. The majority of interventions in the FHP (80) did not have an explicit relationship with any coverage system. Of the 44 interventions that should be provided in PHC but are not included in the FHP, eleven corresponded to GES interventions.</p><p><strong>Conclusions: </strong>The interventions included in the FHP originate from diverse regulatory frameworks, which facilitates discrepancies between some of these coverage regimes and the FHP.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 8","pages":"576-583"},"PeriodicalIF":0.3,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Frequency of Cancer Risk Factors in a Chilean Population]. [智利人口中癌症风险因素的频率]。
IF 0.3 Pub Date : 2025-08-01 DOI: 10.4067/s0034-98872025000800563
Macarena Manríquez-Mimica, Magaly Díaz, Claudia Chávez, Marcela Aguirre, Rodrigo Lagos, Romina Vargas, Jorge Sapunar

Cancer is the leading cause of mortality in Chile. Between 30% and 50% of cancers are related to modifiable risk factors. However, there is insufficient evidence on its distribution in the Chilean population.

Aim: To estimate the frequency of risk factors for the 3 most important oncological pathologies (breast, lung and CRC) in a healthy population affiliated to the cancer insurance of a private cancer center.

Methods: Population-based, cross-sectional study of healthy beneficiaries of cancer insurance at a private cancer center, both sexes, between 40 and 75 years of age during 2021. Data were collected via REDCap® and analyzed in a descriptive and inferential manner, using R v4.04.

Results: 2,091 healthy beneficiaries responded to the survey with a gender distribution of 68% women and 32% men. 64% of the participants had a direct family member with a history of some type of cancer, the most prevalent BMI was the overweight range with a frecuency of 46%, 55% performed physical activity at least 1 time/ week and 19% were active smokers. Of the breast cancer survey (n=851), 66% reported having a family history of cancer ok any kind, and 91% had used some form of contraception, 23.6% had a family history of breast cancer, and 9.3% had a family history of ovarian cancer. In colorectal cancer (n=506), 62,8% had relatives cancer of any kind and 14,4% with CRC, 43.5% reported meat consumption and 25.1% consumption of sausages 2-3 times/week. In lung cancer (n=734), 63,1% had a family history of cancer and 13,2% had a family member with lung cancer. In relation to smoking, 14% reported smoking cigarettes at least once a week, however, 71.6% of smokers expressed the desire to quit smoking.

Conclusions: Although these results are still incipient, and not exactly representative of the Chilean population, these are the first data that aim to collect information on specific risk factors associated with 3 different types of cancer. It is essential to know and quantify the risk factors in our population in order to design prevention programs and alleviate the burden of disease that this diagnosis entails in our country.

在智利,癌症是导致死亡的主要原因。30%至50%的癌症与可改变的危险因素有关。然而,没有足够的证据表明其在智利人口中的分布。目的:估计私立癌症中心癌症保险附属健康人群中3种最重要的肿瘤病理(乳腺癌、肺癌和结直肠癌)的危险因素频率。方法:以人群为基础的横断面研究,研究对象是2021年期间在一家私人癌症中心接受癌症保险的健康受益人,年龄在40至75岁之间,不分性别。通过REDCap®收集数据,并使用R v4.04以描述性和推断性方式进行分析。结果:2,091名健康受益人对调查作出了答复,性别分布为68%的女性和32%的男性。64%的参与者有直系亲属有某种类型的癌症病史,最普遍的BMI是超重范围,频率为46%,55%的人每周至少进行一次体育锻炼,19%的人是活跃的吸烟者。在乳腺癌调查中(n=851), 66%的人报告有某种癌症家族史,91%的人使用过某种形式的避孕措施,23.6%的人有乳腺癌家族史,9.3%的人有卵巢癌家族史。在结直肠癌(n=506)中,62.8%的人有亲属癌症,14.4%的人患有结直肠癌,43.5%的人报告吃肉,25.1%的人每周吃2-3次香肠。在肺癌(n=734)中,63.1%的人有癌症家族史,13.2%的人有家族成员患有肺癌。在吸烟方面,14%的人每周至少抽一次烟,然而,71.6%的吸烟者表示有戒烟的愿望。结论:尽管这些结果仍处于初期阶段,并不能完全代表智利人口,但这是第一个旨在收集与三种不同类型癌症相关的特定风险因素信息的数据。了解和量化我国人口中的风险因素是至关重要的,这样才能设计预防方案,减轻这种诊断在我国带来的疾病负担。
{"title":"[Frequency of Cancer Risk Factors in a Chilean Population].","authors":"Macarena Manríquez-Mimica, Magaly Díaz, Claudia Chávez, Marcela Aguirre, Rodrigo Lagos, Romina Vargas, Jorge Sapunar","doi":"10.4067/s0034-98872025000800563","DOIUrl":"https://doi.org/10.4067/s0034-98872025000800563","url":null,"abstract":"<p><p>Cancer is the leading cause of mortality in Chile. Between 30% and 50% of cancers are related to modifiable risk factors. However, there is insufficient evidence on its distribution in the Chilean population.</p><p><strong>Aim: </strong>To estimate the frequency of risk factors for the 3 most important oncological pathologies (breast, lung and CRC) in a healthy population affiliated to the cancer insurance of a private cancer center.</p><p><strong>Methods: </strong>Population-based, cross-sectional study of healthy beneficiaries of cancer insurance at a private cancer center, both sexes, between 40 and 75 years of age during 2021. Data were collected via REDCap® and analyzed in a descriptive and inferential manner, using R v4.04.</p><p><strong>Results: </strong>2,091 healthy beneficiaries responded to the survey with a gender distribution of 68% women and 32% men. 64% of the participants had a direct family member with a history of some type of cancer, the most prevalent BMI was the overweight range with a frecuency of 46%, 55% performed physical activity at least 1 time/ week and 19% were active smokers. Of the breast cancer survey (n=851), 66% reported having a family history of cancer ok any kind, and 91% had used some form of contraception, 23.6% had a family history of breast cancer, and 9.3% had a family history of ovarian cancer. In colorectal cancer (n=506), 62,8% had relatives cancer of any kind and 14,4% with CRC, 43.5% reported meat consumption and 25.1% consumption of sausages 2-3 times/week. In lung cancer (n=734), 63,1% had a family history of cancer and 13,2% had a family member with lung cancer. In relation to smoking, 14% reported smoking cigarettes at least once a week, however, 71.6% of smokers expressed the desire to quit smoking.</p><p><strong>Conclusions: </strong>Although these results are still incipient, and not exactly representative of the Chilean population, these are the first data that aim to collect information on specific risk factors associated with 3 different types of cancer. It is essential to know and quantify the risk factors in our population in order to design prevention programs and alleviate the burden of disease that this diagnosis entails in our country.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 8","pages":"563-575"},"PeriodicalIF":0.3,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reference Values for the Five-Repetition Sit-to-Stand Test in the Adult Chilean Population. 智利成人五次坐立测试的参考值。
IF 0.3 Pub Date : 2025-08-01 DOI: 10.4067/s0034-98872025000800552
Rodrigo Torres-Castro, Matías Otto-Yáñez, Marisol Barros-Poblete, Carola Valencia, Alex Campos, Leticia Jadue, Marcela Barros, Gonzalo Rivera-Lillo, Lilian Solis-Navarro, Jordi Vilaró

The five-repetition STS test (5-STS) is a field test utilized for evaluating physical function, primarily assessing the risk of falls, and is also included as a component in other assessments, such as the Short Physical Performance Battery (SPPB). This test proves to be easily implementable and of significant clinical utility; however, no reference values are currently available for the Chilean population.

Aim: To establish reference values for the 5-STS in the adult Chilean population.

Methods: A multicenter cross-sectional study encompassed data acquisition from five distinct sites across Chile. Healthy adults aged between 18 and 80 were enrolled as participants. Anthropometric measures, physical activity levels, smoking history, Borg scale assessments, and the time to complete five repetitions were registered. Reference values were subsequently established based on sex and specific age categories.

Results: 463 subjects were included in the study, comprising 269 women. The median (and LIN) of time of 5 repetitions in women was: 18-29 years: 7.4 (10.6), 30-39 years: 7.7 (11.4), 40-49 years: 8.5 (13.1), 50-59 years: 9.2 (14.0), 60-69 years: 9.7 (15.3) and 70-80 years: 11.3 (17.7). While in men it was: 18-29 years: 7.8 (10.3), 30-39 years: 6.5 (11.4), 40-49 years: 8.1 (11.5), 50-59 years: 9.8 (15.1), 60-69 years: 11 (15.8), 70-80 years: 13 (18.5). The predictive equations are as follows: Men: 5-STS= 4.698 + (age(y) * 0.096); Women: 5-STS= -3.185 + (age(y) *0.074) + (height(cm) *0.055).

Conclusion: This study successfully established reference values for the adult Chilean population, providing essential data for the accurate assessment of the physical capacity of the people when using the 5-STS.

五次重复STS测试(5-STS)是一种用于评估身体功能的现场测试,主要是评估跌倒的风险,也被包括在其他评估中,如短物理性能电池(SPPB)。该试验易于实施,具有重要的临床应用价值;但是,目前没有智利人口的参考值。目的:建立智利成人5-STS的参考值。方法:一项多中心横断面研究包括来自智利五个不同地点的数据采集。年龄在18岁至80岁之间的健康成年人被招募为参与者。记录了人体测量值、身体活动水平、吸烟史、博格量表评估和完成5次重复的时间。随后根据性别和具体年龄类别确定了参考值。结果:共纳入463名受试者,其中女性269人。女性5次重复时间的中位数(和LIN)分别为:18-29岁:7.4(10.6),30-39岁:7.7(11.4),40-49岁:8.5(13.1),50-59岁:9.2(14.0),60-69岁:9.7(15.3),70-80岁:11.3(17.7)。而男性:18-29岁:7.8(10.3),30-39岁:6.5(11.4),40-49岁:8.1(11.5),50-59岁:9.8(15.1),60-69岁:11(15.8),70-80岁:13(18.5)。预测方程如下:男性:5-STS= 4.698 +(年龄(y) * 0.096);女人:5-STS = -3.185 +(年龄(y) * 0.074) +(身高(厘米)* 0.055)。结论:本研究成功地为智利成年人群建立了参考值,为使用5-STS时准确评估人们的身体能力提供了必要的数据。
{"title":"Reference Values for the Five-Repetition Sit-to-Stand Test in the Adult Chilean Population.","authors":"Rodrigo Torres-Castro, Matías Otto-Yáñez, Marisol Barros-Poblete, Carola Valencia, Alex Campos, Leticia Jadue, Marcela Barros, Gonzalo Rivera-Lillo, Lilian Solis-Navarro, Jordi Vilaró","doi":"10.4067/s0034-98872025000800552","DOIUrl":"10.4067/s0034-98872025000800552","url":null,"abstract":"<p><p>The five-repetition STS test (5-STS) is a field test utilized for evaluating physical function, primarily assessing the risk of falls, and is also included as a component in other assessments, such as the Short Physical Performance Battery (SPPB). This test proves to be easily implementable and of significant clinical utility; however, no reference values are currently available for the Chilean population.</p><p><strong>Aim: </strong>To establish reference values for the 5-STS in the adult Chilean population.</p><p><strong>Methods: </strong>A multicenter cross-sectional study encompassed data acquisition from five distinct sites across Chile. Healthy adults aged between 18 and 80 were enrolled as participants. Anthropometric measures, physical activity levels, smoking history, Borg scale assessments, and the time to complete five repetitions were registered. Reference values were subsequently established based on sex and specific age categories.</p><p><strong>Results: </strong>463 subjects were included in the study, comprising 269 women. The median (and LIN) of time of 5 repetitions in women was: 18-29 years: 7.4 (10.6), 30-39 years: 7.7 (11.4), 40-49 years: 8.5 (13.1), 50-59 years: 9.2 (14.0), 60-69 years: 9.7 (15.3) and 70-80 years: 11.3 (17.7). While in men it was: 18-29 years: 7.8 (10.3), 30-39 years: 6.5 (11.4), 40-49 years: 8.1 (11.5), 50-59 years: 9.8 (15.1), 60-69 years: 11 (15.8), 70-80 years: 13 (18.5). The predictive equations are as follows: Men: 5-STS= 4.698 + (age(y) * 0.096); Women: 5-STS= -3.185 + (age(y) *0.074) + (height(cm) *0.055).</p><p><strong>Conclusion: </strong>This study successfully established reference values for the adult Chilean population, providing essential data for the accurate assessment of the physical capacity of the people when using the 5-STS.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 8","pages":"552-562"},"PeriodicalIF":0.3,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Multiple Cutaneous Leiomyomas as a Dermatologic Sign of Reed's Syndrome: A Case Report]. [多发性皮肤平滑肌瘤作为里德综合征的皮肤病征象:1例报告]。
IF 0.3 Pub Date : 2025-08-01 DOI: 10.4067/s0034-98872025000800599
Juan Marcelo Riquelme Hermosilla, Lázaro Roque Pérez, Bernardo Morales

Reed syndrome is a rare genodermatosis characterized by the presence of cutaneous leiomyomas, typically of pilar origin, and their association with uterine leiomyomas in women. We present the case of a 23-year-old male patient with a history of papulopustular acne, who developed painful skin lesions on the anterior thorax. Dermoscopic examination and skin biopsy confirmed the diagnosis of piloleiomyomas. Considering the maternal history of multiple cutaneous and uterine leiomyomas, the case was diagnosed as Reed syndrome. Accurate and timely diagnosis of multiple cutaneous leiomyomas is essential, as they are the primary clinical clue for suspecting Reed syndrome-a condition associated with both benign and malignant tumors.

里德综合征是一种罕见的遗传性皮肤病,其特征是存在皮肤平滑肌瘤,典型的支柱起源,并与子宫平滑肌瘤的妇女。我们提出的情况下,一个23岁的男性患者与丘疹性痤疮的历史,谁开发了疼痛的皮肤病变的前胸。皮肤镜检查和皮肤活检证实了毛囊肌瘤的诊断。考虑到母亲有多发性皮肤及子宫平滑肌瘤病史,诊断为里德综合征。多发皮肤平滑肌瘤的准确及时诊断至关重要,因为它们是怀疑Reed综合征的主要临床线索,而Reed综合征是一种与良恶性肿瘤相关的疾病。
{"title":"[Multiple Cutaneous Leiomyomas as a Dermatologic Sign of Reed's Syndrome: A Case Report].","authors":"Juan Marcelo Riquelme Hermosilla, Lázaro Roque Pérez, Bernardo Morales","doi":"10.4067/s0034-98872025000800599","DOIUrl":"https://doi.org/10.4067/s0034-98872025000800599","url":null,"abstract":"<p><p>Reed syndrome is a rare genodermatosis characterized by the presence of cutaneous leiomyomas, typically of pilar origin, and their association with uterine leiomyomas in women. We present the case of a 23-year-old male patient with a history of papulopustular acne, who developed painful skin lesions on the anterior thorax. Dermoscopic examination and skin biopsy confirmed the diagnosis of piloleiomyomas. Considering the maternal history of multiple cutaneous and uterine leiomyomas, the case was diagnosed as Reed syndrome. Accurate and timely diagnosis of multiple cutaneous leiomyomas is essential, as they are the primary clinical clue for suspecting Reed syndrome-a condition associated with both benign and malignant tumors.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"153 8","pages":"599-603"},"PeriodicalIF":0.3,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista medica de Chile
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1